MedCity News
AUGUST 9, 2022
Commercial insurers’ practices, such as prior authorization and white bagging, are needed to reduce costs for patients, said Kristine Grow, senior vice president of communications at AHIP.
Copyright Clearance Center
AUGUST 9, 2022
August 9, 20 22 – Danvers, Mass. – CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, is now offering subscriptions to select publishers including the JAMA Network and the New England Journal of Medicine (NEJM) through CCC’s advanced content workflow solution, RightFind , to meet the needs of researchers in organizations with fewer than 500 employees.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
AUGUST 9, 2022
Clinicians used to wonder if there was a role for mindfulness meditation in healthcare. But after the Covid-19 pandemic laid bare the overwhelming need for practical solutions in behavioral health, the question has shifted to what role it can play.
PM360
AUGUST 9, 2022
PM360 asked life sciences industry experts with knowledge about improving adherence to medication to share the latest trends and approaches being used and to tell us how better data and monitoring can help solve this issue. Specifically, we wanted to know: What are the current biggest trends in how the life sciences industry is approaching ways to improve medication adherence?
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Scott Burrows
AUGUST 9, 2022
Resilience in Pharma Sales: Now More than Ever As a motivational sales speaker for the pharmaceutical industry, I tell my audiences that COVID-19 might also be characterized as the disease that changed an industry. It is kind of ironic.
PM360
AUGUST 9, 2022
How can we help ensure patients continue to take their medications as prescribed? Doctors, caregivers, life sciences companies, and even companies in other industries have attempted to answer this question for as long as medications have been available. But it is not a simple answer. The reasons why a patient may not take their medication are plentiful, and as a result so are the solutions now available to attempt to solve this issue.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
AUGUST 9, 2022
The Penn Medicine-Wharton Fund for Health, Penn’s venture fund focused on social determinants of health, recently announced investments in its fifth and sixth companies. The fund invested in two Philadelphia-based startups, Fabric Health and Stimulus, bringing its total amount of invested capital to $1.35 million.
pharmaphorum
AUGUST 9, 2022
Magnetic resonance imaging (MRI) technology specialist Bot Image has won FDA approval for its artificial intelligence-powered software ProstatID, used for the detection and diagnosis of prostate cancer. The software is combined with traditional MRI scanning to improve the “accuracy and speed” of prostate cancer diagnosis by improving the diagnostic resolution of images, according to the company, which makes it available as a software-as-a-service (SaaS) to radiology departments.
MedCity News
AUGUST 9, 2022
The trifecta of increasing consumerism, staff burnout, and deferred care is a fundamental and new challenge that every healthcare provider in the country must overcome. The solution needs to start at the very start of the care journey when patients are still formulating an opinion of their provider and the care they are likely to receive.
MedReps
AUGUST 9, 2022
“So, can you tell me a little about yourself?” It’s a question we expect but don’t always understand. That’s because the interviewer really wants to know, “Who are you, and why should I consider you a serious candidate?” The introduction, from saying hello to telling your story, is one of the most critical parts of the medical sales interview.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
MedCity News
AUGUST 9, 2022
With the expansion, pending CMS approval, Long Beach, California-based SCAN will reach nearly 7 million potential customers across four states, including California and Arizona.
PM360
AUGUST 9, 2022
Over the course of his career, Adrian Adams has served as CEO of seven different pharma companies, including Aralez Pharmaceuticals, Auxilium Pharmaceuticals, Inspire Pharmaceuticals, Neurologix, Sepracor, and Kos Pharmaceuticals. Most recently, he took over the then-called Impel NeuroPharma in May 2020—at the height of the pandemic—and since then has led the company through its first product approval, undergone an initial public offering (IPO), rebranded to Impel Pharmaceuticals, and attracted
MedCity News
AUGUST 9, 2022
Merck is paying $25 million to kick off a research partnership with Cerevance, a startup that analyzes donor brain tissue to find novel targets for new neurological disorder drugs. While Cerevance’s lead program is a Parkinson’s disease drug, Merck is wants to see if the startup’s technology can help it discover and develop new Alzheimer’s disease drugs.
Copyright Clearance Center
AUGUST 9, 2022
The post How Prince and Warhol Got to the Supreme Court appeared first on Copyright Clearance Center.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
MedCity News
AUGUST 9, 2022
Atropos Health, a startup spun out of Stanford University that provides point-of-care physician consults, recently raised $14 million in Series A funding. The company will use the money to further develop the oncology consult product it is building with ASCO, as well as grow its commercial team.
European Pharmaceutical Review
AUGUST 9, 2022
After a prolonged period of scepticism towards major moves in the mergers and acquisitions (M&A) market, leading biopharmaceutical multinationals are returning to big deal-making. The M&A data for the second quarter of 2022 shows that while both the number of pharma deals signed and their overall value are still low compared to 2021, there are signs of a revival.
MedCity News
AUGUST 9, 2022
With cyber attacks on a steady incline, something needs to be done so that similar fates can be avoided and patient trust can be prioritized. There are four key best practices that, with the right data access technology in place, can protect healthcare companies from hacks and attacks.
European Pharmaceutical Review
AUGUST 9, 2022
Pfizer has entered into a definitive agreement to acquire Global Blood Therapeutics (GBT) , a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing treatments for underserved patient communities, such as those with sickle cell disease (SCD). According to Pfizer, the acquisition complements and further enhances its more than 30-year heritage in rare haematology, reinforcing the company’s commitment to SCD “by bringing expertise and a leading portfolio and
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
PharmaVoice
AUGUST 9, 2022
With Andrew Hall at its helm, IMV has evolved an animal contraceptive into a unique drug delivery platform aimed at creating targeted cancer immunotherapies for humans.
PharmaTimes
AUGUST 9, 2022
Chronic obstructive pulmonary disease phase 3 study shows statistically significant improvements in lung function
Scott’s Directories
AUGUST 9, 2022
The process of making sales to government-run hospitals is quite different from that of making sales to private hospitals. Since government-run hospitals work for the greater good of the entire community, a few crucial factors need to be considered. If you want to use a Winnipeg doctors list , for example, you need to know how to approach them correctly.
PharmaTimes
AUGUST 9, 2022
Patents show potential of innovative Arestat technology and the development of enhanced formulations
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Pharmaceutical Technology
AUGUST 9, 2022
Embracing environmental, social and governance (ESG) criteria is rising in importance as a driver of foreign direct investment (FDI) , with investors increasingly taking into account such criteria as part of their site selection decision. However, when it comes to responsible investing, there is more to it than simply ticking off the 'E', 'S' and 'G'.
PM360
AUGUST 9, 2022
Brand Beat: Juul Fights FDA Ban. Shortly after banning Juul from selling its products, the FDA placed a hold on its decision in order to review the company’s case more closely. At this time, Juul can continue sales in the U.S., however, the company is required to prove to the FDA that their e-cigarettes in fact benefit the public. Juul’s claim is that adults who choose their products are more likely to quit or reduce smoking and teens are unlikely to become addicted to their products.
Pharmaceutical Technology
AUGUST 9, 2022
In the first half of 2022 the number of deals relating to healthtech decreased significantly by 28.7% from the same period in 2021. This marks an acceleration in growth from the 34.7% decrease in deals that occurred in H2 2021 relative to the same period a year earlier. GlobalData's deals database looks at mergers, acquisitions and venture capital and private equity investments taking place daily between thousands of companies across the world.
PM360
AUGUST 9, 2022
According to a 2021 study by Statista, 40% of prescriptions written in 2005 were for brand-name medications. By 2020, that percentage plummeted to just 8%. 1 How is this possible, given that more than 20,000 prescription drugs are currently in circulation in the U.S. 2 and over a million actively licensed physicians 3 are available to prescribe them?
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
CLD, Inc.
AUGUST 9, 2022
Together we will explore the power of storytelling and techniques for incorporating into your sales training. You will learn how storytelling creates order and structure for a sales call, enhances conversations with healthcare providers, and makes them personalized and memorable. In addition, we will provide specifics on how to train your sales force on storytelling techniques, showing representatives how to tailor each story to the interests and needs of the provider and their patients.
PM360
AUGUST 9, 2022
The era of the global pharmaceutical blockbuster is coming to an end. According to ZS research, the top pharma companies have more than $230 billion in worldwide revenues at risk from 2022 to 2030 with an estimated 69 blockbusters expected to lose patents during this time. That is why the industry must move into a new era of global marketing. One in which the heights of blockbuster success may not be possible, but companies can still thrive with more targeted launches around the world.
PharmExec
AUGUST 9, 2022
Proximyl Health’s Halen Dang, VP, Creative Director of Art and Carrie Morris, VP, Creative Director of Copy discuss remote teamwork and how to successfully lead agency creative teams with hybrid schedules.
Pharmaceutical Technology
AUGUST 9, 2022
Mentions of artificial intelligence within the filings of companies in the pharmaceutical industry fell 24% between the first and second quarters of 2022. In total, the frequency of sentences related to artificial intelligence between July 2021 and June 2022 was 400% higher than in 2016 when GlobalData, from whom our data for this article is taken, first began to track the key issues referred to in company filings.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
122 
Let's personalize your content